Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Reni M, Cordio S, Milandri C, et al. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre Phase III trial. Lancet Oncol. 2005;6(6):369–376. doi:10.1016/S1470-2045(05)70175-3
   PubMed Web of Science ®Google Scholar
• Abbruzzese JL, Grunewald R, Weeks EA, et al. A Phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol. 1991;9(3):491–498. doi:10.1200/JCO.1991.9.3.491
   PubMed Web of Science ®Google Scholar
• Reid JM, Qu W, Safgren SL, et al. Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors. J Clin Oncol. 2004;22(12):2445–2451. doi:10.1200/JCO.2004.10.142
   PubMed Web of Science ®Google Scholar
• Moog R, Burger A, Brandl M, et al. Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels. Cancer Chemother Pharmacol. 2002;49(5):356–366. doi:10.1007/s00280-002-0428-4
   PubMed Web of Science ®Google Scholar
• Immordino ML, Brusa P, Rocco F, Arpicco S, Ceruti M, Cattel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. J Control Release. 2004;100(3):331–346. doi:10.1016/j.jconrel.2004.09.001
   PubMed Web of Science ®Google Scholar
• Derakhshandeh K, Fathi S. Role of chitosan nanoparticles in the oral absorption of Gemcitabine. Int J Pharm. 2012;437(1–2):172–177. doi:10.1016/j.ijpharm.2012.08.008
   PubMed Web of Science ®Google Scholar
• Kawazoe H, Mori N, Ido S, et al. Liquid formulation of gemcitabine increases venous pain in patients with cancer: a retrospective study. Clin Ther. 2020;42(4):712–719. doi:10.1016/j.clinthera.2020.02.010
   PubMed Web of Science ®Google Scholar
• Arciero V, Luo J, Parmar A, et al. Real-world cost-effectiveness of first-line gemcitabine plus nab-paclitaxel vs FOLFIRINOX in patients with advanced pancreatic cancer. JNCI Cancer Spectr. 2022;6(4). doi:10.1093/jncics/pkac047
   PubMed Web of Science ®Google Scholar
• Plunkett W, Huang P, Xu YZ, Heinemann V, Grunewald R, Gandhi V. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol. 1995;22(4):3–10.
   PubMed Web of Science ®Google Scholar
• Samanta K, Setua S, Kumari S, Jaggi M, Yallapu MM, Chauhan SC. Gemcitabine combination nano therapies for pancreatic cancer. Pharmaceutics. 2019;11(11):574. doi:10.3390/pharmaceutics11110574
   PubMed Web of Science ®Google Scholar
• Tan M, Luo J, Tian Y. Delivering curcumin and gemcitabine in one nanoparticle platform for colon cancer therapy. RSC Adv. 2014;4(106):61948–61959. doi:10.1039/C4RA10431E
   Web of Science ®Google Scholar
• Semaan A, Maitra A. Rebooting pancreatic cancer knowledge and treatment options. Nat Rev Gastroenterol Hepatol. 2018;15(2):76–78. doi:10.1038/nrgastro.2017.182
   PubMed Web of Science ®Google Scholar
• Adiseshaiah PP, Crist RM, Hook SS, McNeil SE. Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nat Rev Clin Oncol. 2016;13(12):750–765. doi:10.1038/nrclinonc.2016.119
   PubMed Web of Science ®Google Scholar
• Bastiancich C, Vanvarenberg K, Ucakar B, et al. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma. J Control Release. 2016;225:283–293. doi:10.1016/j.jconrel.2016.01.054
   PubMed Web of Science ®Google Scholar
• Bastiancich C, Bianco J, Vanvarenberg K, et al. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection. J Control Release. 2017;264:45–54. doi:10.1016/j.jconrel.2017.08.019
   PubMed Web of Science ®Google Scholar
• Qin L, Ling G, Peng F, et al. Black phosphorus nanosheets and gemcitabine encapsulated thermo-sensitive hydrogel for synergistic photothermal-chemotherapy. J Colloid Interface Sci. 2019;556:232–238. doi:10.1016/j.jcis.2019.08.058
   PubMed Web of Science ®Google Scholar
• Schneible JD, Shi K, Young AT, et al. Modified graphene oxide (GO) particles in peptide hydrogels: a hybrid system enabling scheduled delivery of synergistic combinations of chemotherapeutics. J Mater Chem B. 2020;8(17):3852. doi:10.1039/D0TB00064G
   PubMed Web of Science ®Google Scholar
• Moysan E, González-Fernández Y, Lautram N, Béjaud J, Bastiat G, Benoit JP. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure. Soft Matter. 2014;10(11):1767–1777. doi:10.1039/c3sm52781f
   PubMed Web of Science ®Google Scholar
• Bilalis P, Skoulas D, Karatzas A, et al. Self-healing pH- and enzyme stimuli-responsive hydrogels for targeted delivery of gemcitabine to treat pancreatic cancer. Biomacromolecules. 2018;19(9):3840–3852. doi:10.1021/acs.biomac.8b00959
   PubMed Web of Science ®Google Scholar
• Wang J, Leng Q, Li Y, et al. Injectable hyaluronic acid hydrogel for the co-delivery of gemcitabine nanoparticles and cisplatin for malignant ascites therapy. J Biomed Nanotechnol. 2020;16(12):1727–1739. doi:10.1166/jbn.2020.3002
   PubMed Web of Science ®Google Scholar
• Wu W, Dai Y, Liu H, et al. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma. Drug Deliv. 2018;25(1):1642. doi:10.1080/10717544.2018.1497105
   PubMed Web of Science ®Google Scholar
• Wang W, Wang B, Liu S, et al. Bioreducible polymer nanocarrier based on multivalent choline phosphate for enhanced cellular uptake and intracellular delivery of doxorubicin. ACS Appl Mater Interfaces. 2017;9(19):15986–15994. doi:10.1021/acsami.7b03317
   PubMed Web of Science ®Google Scholar
• Bastiancich C, Bozzato E, Luyten U, Danhier F, Bastiat G, Préat V. Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment. Int J Pharm. 2019;559:220–227. doi:10.1016/j.ijpharm.2019.01.042
   PubMedGoogle Scholar
• Zhuang B, Chen T, Xiao Z, Jin Y. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence. Int J Pharm. 2020;577:119048. doi:10.1016/j.ijpharm.2020.119048
   PubMedGoogle Scholar
• Schneible JD, Young AT, Daniele MA, Menegatti S. Chitosan hydrogels for synergistic delivery of chemotherapeutics to triple negative breast cancer cells and spheroids. Pharm Res. 2020;37(7). doi:10.1007/s11095-020-02864-2
   PubMed Web of Science ®Google Scholar
• Shabana AM, Kambhampati SP, ching HR, Kannan RM, Kokkoli E. Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained co-delivery of gemcitabine and paclitaxel to pancreatic cancer cells. Int J Pharm. 2021;593:120139. doi:10.1016/j.ijpharm.2020.120139
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang G, Liu G, Hu J, Liu S. Photo- and thermo-responsive multicompartment hydrogels for synergistic delivery of gemcitabine and doxorubicin. J Control Release. 2017;259:149–159. doi:10.1016/j.jconrel.2016.11.007
   PubMed Web of Science ®Google Scholar
• Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-The-art. J Control Release. 2016;240:504–526. doi:10.1016/j.jconrel.2016.06.016
   PubMed Web of Science ®Google Scholar
• Des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1–27. doi:10.1016/j.jconrel.2006.08.013
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64(6):557–570. doi:10.1016/j.addr.2011.12.009
   PubMed Web of Science ®Google Scholar
• Kim KS, Suzuki K, Cho H, Youn YS, Bae YH. Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport. ACS Nano. 2018;12(9):8893–8900. doi:10.1021/acsnano.8b04315
   PubMed Web of Science ®Google Scholar
• Beloqui A, Des Rieux A, Préat V. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier. Adv Drug Deliv Rev. 2016;106(Pt B):242–255. doi:10.1016/j.addr.2016.04.014
   PubMedGoogle Scholar
• Jin L, Wang Q, Chen J, Wang Z, Xin H, Zhang D. Efficient delivery of therapeutic siRNA by Fe3O4 magnetic nanoparticles into oral cancer cells. Pharmaceutics. 2019;11(11):615. doi:10.3390/pharmaceutics11110615
   PubMed Web of Science ®Google Scholar
• Zhang W, Zheng N, Chen L, et al. Effect of shape on mesoporous silica nanoparticles for oral delivery of indomethacin. Pharmaceutics. 2019;11(1):4.
   Web of Science ®Google Scholar
• Lamson NG, Berger A, Fein KC, Whitehead KA. Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability. Nat Biomed Eng. 2020;4(1):84–96. doi:10.1038/s41551-019-0465-5
   PubMed Web of Science ®Google Scholar
• Du X, Yin S, Xu L, et al. Polylysine and cysteine functionalized chitosan nanoparticle as an efficient platform for oral delivery of paclitaxel. Carbohydr Polym. 2020;229:115484. doi:10.1016/j.carbpol.2019.115484
   PubMed Web of Science ®Google Scholar
• Sorasitthiyanukarn FN, Muangnoi C, Ratnatilaka Na Bhuket P, Rojsitthisak P, Rojsitthisak P. Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment. Mater Sci Eng C Mater Biol Appl. 2018;93:178–190. doi:10.1016/j.msec.2018.07.069
   PubMed Web of Science ®Google Scholar
• Khan AA, Mudassir J, Akhtar S, Murugaiyah V, Darwis Y. Freeze-dried lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: statistical optimization, in vitro and in vivo evaluations. Pharmaceutics. 2019;11(2):97. doi:10.3390/pharmaceutics11020097
   PubMed Web of Science ®Google Scholar
• Hanurry EY, Mekonnen TW, Andrgie AT, et al. Biotin-decorated PAMAM G4.5 dendrimer nanoparticles to enhance the delivery, anti-proliferative, and apoptotic effects of chemotherapeutic drug in cancer cells. Pharmaceutics. 2020;12(5):443. doi:10.3390/pharmaceutics12050443
   PubMed Web of Science ®Google Scholar
• Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000;50(1):27–46. doi:10.1016/S0939-6411(00)00090-4
   PubMed Web of Science ®Google Scholar
• Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev. 2001;53(3):321–339. doi:10.1016/S0169-409X(01)00203-4
   PubMed Web of Science ®Google Scholar
• Peppas NA, Hilt JZ, Khademhosseini A, Langer R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater. 2006;18(11):1345–1360. doi:10.1002/adma.200501612
   Web of Science ®Google Scholar
• Hoare TR, Kohane DS. Hydrogels in drug delivery: progress and challenges. Polymer. 2008;49(8):1993–2007. doi:10.1016/j.polymer.2008.01.027
   Web of Science ®Google Scholar
• Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nature Rev Mater. 2016;1(12):1–17. doi:10.1038/natrevmats.2016.71
   Web of Science ®Google Scholar
• Chen W, Zou Y, Zhong Z, Haag R. Cyclo(RGD)-decorated reduction-responsive nanogels mediate targeted chemotherapy of integrin overexpressing human glioblastoma in vivo. Small. 2017;13(6):1601997.
   Web of Science ®Google Scholar
• Cuggino JC, Molina M, Wedepohl S, Igarzabal CIA, Calderón M, Gugliotta LM. Responsive nanogels for application as smart carriers in endocytic pH-triggered drug delivery systems. Eur Polym J. 2016;78:14–24. doi:10.1016/j.eurpolymj.2016.02.022
   Web of Science ®Google Scholar
• Cuggino JC, Gatti G, Picchio ML, Maccioni M, Gugliotta LM, Alvarez Igarzabal CI. Dually responsive nanogels as smart carriers for improving the therapeutic index of doxorubicin for breast cancer. Eur Polym J. 2019;116:445–452. doi:10.1016/j.eurpolymj.2019.04.031
   Web of Science ®Google Scholar
• Hajebi S, Rabiee N, Bagherzadeh M, et al. Stimulus-responsive polymeric nanogels as smart drug delivery systems. Acta Biomater. 2019;92:1. doi:10.1016/j.actbio.2019.05.018
   PubMed Web of Science ®Google Scholar
• Liu B, Thayumanavan S. Substituent effects on the pH sensitivity of acetals and ketals and their correlation with encapsulation stability in polymeric nanogels. J Am Chem Soc. 2017;139(6):2306–2317. doi:10.1021/jacs.6b11181
   PubMed Web of Science ®Google Scholar
• Liechty WB, Peppas NA. Expert opinion: responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm. 2012;80(2):241–246. doi:10.1016/j.ejpb.2011.08.004
   PubMed Web of Science ®Google Scholar
• Maya S, Sarmento B, Nair A, Rejinold N, Nair S, Jayakumar R. Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review. Curr Pharm Des. 2013;19(41):7203–7218. doi:10.2174/138161281941131219124142
   PubMed Web of Science ®Google Scholar
• Oishi M, Nagasaki Y. Stimuli-responsive smart nanogels for cancer diagnostics and therapy. Nanomedicine. 2010;5(3):451–468. doi:10.2217/nnm.10.18
   PubMed Web of Science ®Google Scholar
• Li C, Obireddy SR, Lai WF. Preparation and use of nanogels as carriers of drugs. Drug Deliv. 2021;28(1):1594. doi:10.1080/10717544.2021.1955042
   PubMed Web of Science ®Google Scholar
• Cuggino JC, Blanco ERO, Gugliotta LM, Alvarez Igarzabal CI, Calderón M. Crossing biological barriers with nanogels to improve drug delivery performance. J Control Release. 2019;307:221–246. doi:10.1016/j.jconrel.2019.06.005
   PubMed Web of Science ®Google Scholar
• Kersey FR, Merkel TJ, Perry JL, Napier ME, Desimone JM. Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores. Langmuir. 2012;28(23):8773–8781. doi:10.1021/la301279v
   PubMed Web of Science ®Google Scholar
• Shirahama H, Lee BH, Tan LP, Cho NJ. Precise tuning of facile one-pot gelatin methacryloyl (GelMA) synthesis. Sci Rep. 2016;6(1):1–11. doi:10.1038/srep31036
   PubMedGoogle Scholar
• Hoch E, Hirth T, Tovar GEM, Borchers K. Chemical tailoring of gelatin to adjust its chemical and physical properties for functional bioprinting. J Mater Chem B. 2013;1(41):5675–5685. doi:10.1039/c3tb20745e
   PubMed Web of Science ®Google Scholar
• Kang MG, Lee MY, Cha JM, et al. Nanogels derived from fish gelatin: application to drug delivery system. Mar Drugs. 2019;17(4):246. doi:10.3390/md17040246
   PubMed Web of Science ®Google Scholar
• Kim J, Gauvin R, Yoon HJ, et al. Skin penetration-inducing gelatin methacryloyl nanogels for transdermal macromolecule delivery. Macromol Res. 2016;24(12):1115–1125. doi:10.1007/s13233-016-4147-9
   Web of Science ®Google Scholar
• Novakova I, Subileau EA, Toegel S, et al. Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models. PLoS One. 2014;9(1):e86806. doi:10.1371/journal.pone.0086806
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy S, Noorani B, Xu C. Effects of encapsulated cells on the physical–mechanical properties and microstructure of gelatin methacrylate hydrogels. Int J Mol Sci. 2019;20(20):5061. doi:10.3390/ijms20205061
   PubMed Web of Science ®Google Scholar
• Lee BH, Shirahama H, Cho NJ, Tan LP. Efficient and controllable synthesis of highly substituted gelatin methacrylamide for mechanically stiff hydrogels. RSC Adv. 2015;5(128):106094–106097. doi:10.1039/C5RA22028A
   Web of Science ®Google Scholar
• Sun M, Sun X, Wang Z, Guo S, Yu G, Yang H. Synthesis and properties of gelatin methacryloyl (GelMA) hydrogels and their recent applications in load-bearing tissue. Polymers. 2018;10(11):1290. doi:10.3390/polym10111290
   PubMed Web of Science ®Google Scholar
• Pinelli F, Ferracin F, Perale G, Rossi F. Synthesis and applications of nanogels via covalent cross-linking strategies. Adv Chem Engineer. 2023;62:35–58.
   Google Scholar
• Rizwan M, Yahya R, Hassan A, et al. pH sensitive hydrogels in drug delivery: brief history, properties, swelling, and release mechanism, material selection and applications. Polymers. 2017;9(4):137.
   PubMed Web of Science ®Google Scholar
• Bashir S, Hina M, Iqbal J, et al. Fundamental concepts of hydrogels: synthesis, properties, and their applications. Polymers. 2020;12(11):1–60. doi:10.3390/POLYM12112702
   Web of Science ®Google Scholar
• Jacob S, Nair AB, Shah J, Sreeharsha N, Gupta S, Shinu P. Emerging role of hydrogels in drug delivery systems, tissue engineering and wound management. Pharmaceutics. 2021;13(3):357. doi:10.3390/pharmaceutics13030357
   PubMed Web of Science ®Google Scholar
• Cheng G, Zielonka J, McAllister D, Tsai S, Dwinell MB, Kalyanaraman B. Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. Br J Cancer. 2014;111(1):85–93. doi:10.1038/bjc.2014.272
   PubMed Web of Science ®Google Scholar
• Jaidev LR, Krishnan UM, Sethuraman S. Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy. Mater Sci Eng C Mater Biol Appl. 2015;47:40–47. doi:10.1016/j.msec.2014.11.027
   PubMed Web of Science ®Google Scholar
• Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 2015;20(2):107–126. doi:10.1177/2211068214561025
   PubMedGoogle Scholar
• Derissen EJB, Huitema ADR, Rosing H, Schellens JHM, Beijnen JH. Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2′,2′‐difluorodeoxyuridine and their nucleotides. Br J Clin Pharmacol. 2018;84(6):1279. doi:10.1111/bcp.13557
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan W, Dai X, et al. Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles. Mol Pharm. 2014;11(4):1140–1150. doi:10.1021/mp4005904
   PubMedGoogle Scholar
• Soni KS, Desale SS, Bronich TK. Nanogels: an overview of properties, biomedical applications and obstacles to clinical translation. J Control Release. 2016;240:109. doi:10.1016/j.jconrel.2015.11.009
   PubMed Web of Science ®Google Scholar